Investor mix
4 investors on record; lead investors include Xiamen Financial Investment Group, Kaitai Capital Management.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Private equity | 1 | 25% |
| Other / undisclosed | 2 | 50% |
Manufacturer of APIs and pharmaceutical intermediates
4 investors on record; lead investors include Xiamen Financial Investment Group, Kaitai Capital Management.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Private equity | 1 | 25% |
| Other / undisclosed | 2 | 50% |